tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

ZLAB Stock Latest News

Zai Lab Ltd’s Earnings Call: Mixed Outlook Amid Growth and Challenges
Company AnnouncementsZai Lab Ltd’s Earnings Call: Mixed Outlook Amid Growth and Challenges
10d ago
ZLAB
Zai Lab Reports Strong Q3 2025 Growth and Pipeline Progress
PremiumCompany Announcements
Zai Lab Reports Strong Q3 2025 Growth and Pipeline Progress
11d ago
ZLAB
Zai Lab reports Q3 EPS (3c), consensus (29c)
PremiumThe Fly
Zai Lab reports Q3 EPS (3c), consensus (29c)
11d ago
ZLAB
Zai Lab sees FY25 revenue at least $460M, consensus $556.41M
PremiumThe Fly
Zai Lab sees FY25 revenue at least $460M, consensus $556.41M
11d ago
ZLAB
Zai Lab removed from APAC Conviction List at Goldman Sachs
PremiumThe Fly
Zai Lab removed from APAC Conviction List at Goldman Sachs
14d ago
ZLAB
Promising Clinical Results and Strategic Developments Drive Buy Rating for Zai Lab
PremiumRatingsPromising Clinical Results and Strategic Developments Drive Buy Rating for Zai Lab
21d ago
ZLAB
Zai Lab Secures RMB300 Million Debt Facility
Premium
Company Announcements
Zai Lab Secures RMB300 Million Debt Facility
1M ago
8K
ZLAB
Zai Lab falls -6.9%
Premium
The Fly
Zai Lab falls -6.9%
1M ago
ZLAB
Zai Lab’s Strategic Positioning and Competitive Edge in SCLC Treatment Justifies Buy Rating
PremiumRatings
Zai Lab’s Strategic Positioning and Competitive Edge in SCLC Treatment Justifies Buy Rating
2M ago
ZLAB
Zai Lab to wait on results of FORTITUDE-102 prior to regulatory filing
PremiumThe Fly
Zai Lab to wait on results of FORTITUDE-102 prior to regulatory filing
3M ago
AMGN
ZLAB
Zai Lab announces approval of TIVDAK in Hong Kong
PremiumThe Fly
Zai Lab announces approval of TIVDAK in Hong Kong
3M ago
ZLAB
Zai Lab Ltd’s Earnings Call Highlights Growth and Profitability Path
PremiumCompany Announcements
Zai Lab Ltd’s Earnings Call Highlights Growth and Profitability Path
3M ago
ZLAB
Zai Lab’s Growth Potential and Global Expansion: A Strong Buy Recommendation
PremiumRatingsZai Lab’s Growth Potential and Global Expansion: A Strong Buy Recommendation
3M ago
ZLAB
Zai Lab price target raised to $69 from $66 at Citi
Premium
The Fly
Zai Lab price target raised to $69 from $66 at Citi
3M ago
ZLAB
Zai Lab Reports Growth and Strategic Progress in Q2 2025
Premium
Company Announcements
Zai Lab Reports Growth and Strategic Progress in Q2 2025
3M ago
ZLAB
Zai Lab reports Q2 EPS (4c), consensus (42c)
PremiumThe Fly
Zai Lab reports Q2 EPS (4c), consensus (42c)
3M ago
ZLAB
Zai Lab’s Promising Phase 3 Trial Results and Future Potential Justify Buy Rating
PremiumRatings
Zai Lab’s Promising Phase 3 Trial Results and Future Potential Justify Buy Rating
5M ago
ZLAB
Zai Lab’s Promising Growth: Successful Trial and Expanding Pipeline Drive Buy Rating
PremiumRatings
Zai Lab’s Promising Growth: Successful Trial and Expanding Pipeline Drive Buy Rating
5M ago
ZLAB
Zai Lab price target raised to $75 from $73 at Leerink
PremiumThe Fly
Zai Lab price target raised to $75 from $73 at Leerink
5M ago
AMGN
ZLAB
Zai Lab announces FORTITUDE-101 clinical trial meets primary endpoint
PremiumThe FlyZai Lab announces FORTITUDE-101 clinical trial meets primary endpoint
5M ago
ZLAB
Zai Lab Shareholders Approve Key Proposals at AGM
Premium
Company Announcements
Zai Lab Shareholders Approve Key Proposals at AGM
5M ago
8K
ZLAB
Zai Lab announces new data from preclinical study of ZL-1503
Premium
The Fly
Zai Lab announces new data from preclinical study of ZL-1503
5M ago
ZLAB

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >